These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 15270095
21. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Kotner J, Tarleton R. Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658 [Abstract] [Full Text] [Related]
22. T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection. Cobb D, Hambright D, Smeltz RB. J Leukoc Biol; 2010 Nov; 88(5):965-71. PubMed ID: 20807701 [Abstract] [Full Text] [Related]
23. B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection. Cardillo F, Postol E, Nihei J, Aroeira LS, Nomizo A, Mengel J. Immunology; 2007 Dec; 122(4):584-95. PubMed ID: 17635611 [Abstract] [Full Text] [Related]
24. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Duthie MS, Wleklinski-Lee M, Smith S, Nakayama T, Taniguchi M, Kahn SJ. Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161 [Abstract] [Full Text] [Related]
26. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM. Vaccine; 2009 Sep 18; 27(41):5644-53. PubMed ID: 19635607 [Abstract] [Full Text] [Related]
27. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection. Graefe SE, Jacobs T, Wächter U, Bröker BM, Fleischer B. Parasite Immunol; 2004 Jan 18; 26(1):19-28. PubMed ID: 15198642 [Abstract] [Full Text] [Related]
28. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. Tarleton RL, Kuhn RE. J Immunol; 1984 Sep 18; 133(3):1570-5. PubMed ID: 6431001 [Abstract] [Full Text] [Related]
29. Trypanosoma cruzi: do different sylvatic strains trigger distinct immune responses? Caetano LC, do Prado JC, Toldo MP, Abrahão AA. Exp Parasitol; 2010 Feb 18; 124(2):219-24. PubMed ID: 19786023 [Abstract] [Full Text] [Related]
30. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice. Wendelken JL, Rowland EC. J Parasitol; 2009 Apr 18; 95(2):337-44. PubMed ID: 18922039 [Abstract] [Full Text] [Related]
31. Inhibition of Trypanosoma cruzi egress from infected fibroblasts is mediated by CD4+ and mu+ immune cells. Rowland EC, Chen Z. J Parasitol; 2003 Aug 18; 89(4):733-7. PubMed ID: 14533683 [Abstract] [Full Text] [Related]
32. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Lieke T, Graefe SE, Klauenberg U, Fleischer B, Jacobs T. Infect Immun; 2004 Dec 18; 72(12):6817-25. PubMed ID: 15557602 [Abstract] [Full Text] [Related]
33. Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi. Dominguez MR, Ersching J, Lemos R, Machado AV, Bruna-Romero O, Rodrigues MM, de Vasconcelos JR. Vaccine; 2012 Apr 16; 30(18):2882-91. PubMed ID: 22381075 [Abstract] [Full Text] [Related]
34. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes. Frank FM, Petray PB, Cazorla SI, Muñoz MC, Corral RS, Malchiodi EL. Vaccine; 2003 Dec 08; 22(1):77-86. PubMed ID: 14604574 [Abstract] [Full Text] [Related]
35. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection. Tonelli RR, Torrecilhas AC, Jacysyn JF, Juliano MA, Colli W, Alves MJ. Parasitology; 2011 Apr 08; 138(4):481-92. PubMed ID: 21040619 [Abstract] [Full Text] [Related]
36. Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice. Garzón E, Borges MC, Cordeiro-da-Silva A, Nacife V, Meirelles Mde N, Guilvard E, Bosseno MF, Guevara AG, Brenière SF, Ouaissi A. Immunol Lett; 2003 Oct 09; 89(1):67-80. PubMed ID: 12946866 [Abstract] [Full Text] [Related]
37. Antiegressin acts late in the intracellular growth cycle of Trypanosoma cruzi to inhibit parasite egress. Moore-Lai D, Rowland EC. J Parasitol; 2004 Feb 09; 90(1):85-91. PubMed ID: 15040671 [Abstract] [Full Text] [Related]
38. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection. Esper L, Utsch L, Soriani FM, Brant F, Esteves Arantes RM, Campos CF, Pinho V, Souza DG, Teixeira MM, Tanowitz HB, Vieira LQ, Machado FS. Microbes Infect; 2014 Jun 09; 16(6):481-90. PubMed ID: 24704475 [Abstract] [Full Text] [Related]
39. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Reyes JL, Terrazas LI, Espinoza B, Cruz-Robles D, Soto V, Rivera-Montoya I, Gómez-García L, Snider H, Satoskar AR, Rodríguez-Sosa M. Infect Immun; 2006 Jun 09; 74(6):3170-9. PubMed ID: 16714544 [Abstract] [Full Text] [Related]
40. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Lopes MF, Nunes MP, Henriques-Pons A, Giese N, Morse HC, Davidson WF, Araújo-Jorge TC, DosReis GA. Eur J Immunol; 1999 Jan 09; 29(1):81-9. PubMed ID: 9933089 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]